A SPECIFIC, HIGH-AFFINITY, SATURABLE BINDING-SITE FOR THE 16-KILODALTON FRAGMENT OF PROLACTIN ON CAPILLARY ENDOTHELIAL-CELLS

被引:131
作者
CLAPP, C [1 ]
WEINER, RI [1 ]
机构
[1] NATL AUTONOMOUS UNIV MEXICO,INST INVEST BIOMED,DEPT FISIOL,MEXICO CITY 04510,DF,MEXICO
关键词
D O I
10.1210/en.130.3.1380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 16-kilodalton N-terminal fragment of PRL (16K PRL) is formed by enzymatic cleavage of intact 23-kilodalton PRL (23K PRL) in the pituitary gland and in target tissues for PRL. 16K PRL inhibits the growth of capillary endothelial cells, while intact PRL was inactive suggesting that 16K PRL acted via a receptor other than the PRL receptor. To analyze whether this inhibitory effect could be mediated through an specific 16K PRL receptor, we characterized the binding of 16K PRL to membrane preparations of bovine brain capillary endothelial (BBE) cells. 16K PRL was generated by the proteolysis of rat 23K PRL with a particulate fraction from rat mammary gland homogenates and purified by gel filtration. The specific binding of [I-125]16K PRL to BBE cell membranes was high affinity (K(d) = 9.9 nM), saturable (B(max) = 4.8 pmol/mg protein), and reversible. In competition studies for [I-125]16K PRL binding, 16K PRL was most potent, while little displacement was observed with high concentrations of 23K PRLs, growth hormones, and basic fibroblast growth factor. Blockade of reformation of disulfide bonds by carbamidomethylation of 16K PRL, a procedure which increases the biological activity of the molecule, increased its binding affinity (K(d) = 0.9 nM). Cross-linking experiments identified a 52,000 and a 32,000 mol wt protein as the major 16K PRL binding species. These data demonstrate the presence of specific, high affinity, saturable binding sites for 16K PRL on BBE cell membranes and support biological findings that 16K PRL inhibits capillary endothelial cell proliferation, through a novel, high affinity receptor.
引用
收藏
页码:1380 / 1386
页数:7
相关论文
共 42 条
  • [31] LIMBIRD LE, 1986, CELL SURFACE RECEPTO, P60
  • [34] THE MURINE INTERLEUKIN-4 RECEPTOR - MOLECULAR-CLONING AND CHARACTERIZATION OF SECRETED AND MEMBRANE-BOUND FORMS
    MOSLEY, B
    BECKMANN, MP
    MARCH, CJ
    IDZERDA, RL
    GIMPEL, SD
    VANDENBOS, T
    FRIEND, D
    ALPERT, A
    ANDERSON, D
    JACKSON, J
    WIGNALL, JM
    SMITH, C
    GALLIS, B
    SIMS, JE
    URDAL, D
    WIDMER, MB
    COSMAN, D
    PARK, LS
    [J]. CELL, 1989, 59 (02) : 335 - 348
  • [35] Niall H. D., 1981, Prolactin, P1
  • [36] RODBARD D, 1974, CLIN CHEM, V20, P1255
  • [37] SAKAI S, 1987, ENDOCRINOL JPN, V36, P863
  • [38] RECEPTOR-MEDIATED MITOGENIC ACTION OF PROLACTIN IN A RAT LYMPHOMA CELL-LINE
    SHIU, RPC
    ELSHOLTZ, HP
    TANAKA, T
    FRIESEN, HG
    GOUT, PW
    BEER, CT
    NOBLE, RL
    [J]. ENDOCRINOLOGY, 1983, 113 (01) : 159 - 165
  • [39] A CLEAVED FORM OF PROLACTIN IN THE MOUSE PITUITARY-GLAND - IDENTIFICATION AND COMPARISON OF INVITRO SYNTHESIS AND RELEASE IN STRAINS WITH HIGH AND LOW INCIDENCES OF MAMMARY-TUMORS
    SINHA, YN
    GILLIGAN, TA
    [J]. ENDOCRINOLOGY, 1984, 114 (06) : 2046 - 2053
  • [40] CLEAVED PROLACTIN - EVIDENCE FOR ITS OCCURRENCE IN HUMAN PITUITARY-GLAND AND PLASMA
    SINHA, YN
    GILLIGAN, TA
    LEE, DW
    HOLLINGSWORTH, D
    MARKOFF, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (02) : 239 - 243